Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on August 7, 2026

Aug. 7, 2026

Understanding the September 30 EB-5 Deadline: What It Means for Investors

Indeterminate EIN Presswire

Aug. 7, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 7, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 7, 2026

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders

Indeterminate GlobeNewswire

Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Parks! America, Inc. Reports Third Quarter Fiscal 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 7, 2026

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

Amwell makes grant to new employees under inducement plan

Indeterminate GlobeNewswire

Aug. 7, 2026

MICROSOFT CLASS ACTION DEADLINE TUESDAY AUGUST 11th: Bragar Eagel & Squire, P.C. Urges Microsoft Corporation Investors to Contact the Firm Regarding Lead Plaintiff Role

Indeterminate GlobeNewswire

Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

Aug. 7, 2026

Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 30 juin 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire

Aug. 7, 2026

Terra Balcanica Announces Extension to Private Placement Financing

Indeterminate GlobeNewswire